| 2024-05-09 | Eledon Pharmaceuticals, Inc. ELDN | 10 percent owner | 1.93M 7.8677% | $2.37 | $4.57M | +17.3% | ||
| 2023-11-16 | Repare Therapeutics Inc. RPTX | 10 percent owner | 295,745 0.6815% | $5.38 | $1.59M | -6.13% | ||
| 2023-11-15 | Repare Therapeutics Inc. RPTX | 10 percent owner | 931,556 2.0265% | $5.00 | $4.66M | -4.4% | ||
| 2023-11-03 | Kymera Therapeutics, Inc. KYMR | director | 197,699 0.3518% | $14.07 | $2.78M | +136.65% | ||
| 2023-11-02 | Kymera Therapeutics, Inc. KYMR | director | 216,406 0.3771% | $11.64 | $2.52M | +178.93% | ||
| 2023-11-02 | Repare Therapeutics Inc. RPTX | 10 percent owner | 783,709 1.8363% | $3.60 | $2.82M | +41.99% | ||
| 2023-09-12 | Olema Pharmaceuticals, Inc. OLMA | 1.51M 2.9937% | $9.84 | $14.82M | +1.13% | |||
| 2023-05-05 | Eledon Pharmaceuticals, Inc. ELDN | 10 percent owner | 1.98M 11.9399% | $2.31 | $4.57M | -41.42% | ||
| 2023-01-12 | Kymera Therapeutics, Inc. KYMR | director | 18,897 0.0302% | $31.24 | $590,391 | -26.07% | ||
| 2023-01-11 | Kymera Therapeutics, Inc. KYMR | director | 22,110 0.038% | $29.89 | $660,799 | -16.97% | ||
| 2023-01-06 | XOMA Corporation XOMA | director | 1,573 0.0137% | $21.98 | $34,577 | -19.69% | ||
| 2023-01-06 | XOMA Corporation XOMA | director | 3,249 0.0282% | $21.98 | $71,419 | -19.69% | ||
| 2023-01-05 | XOMA Corporation XOMA | director | 15,670 0.1152% | $18.39 | $288,096 | -18.64% | ||
| 2023-01-05 | XOMA Corporation XOMA | director | 19,000 0.1396% | $18.39 | $349,319 | -18.64% | ||
| 2022-01-31 | Kymera Therapeutics, Inc. KYMR | director | 34,408 0.0646% | $40.70 | $1.4M | -33.05% | ||
| 2022-01-27 | Kymera Therapeutics, Inc. KYMR | director | 95,901 0.1917% | $38.33 | $3.68M | -24.25% | ||
| 2022-01-24 | Kymera Therapeutics, Inc. KYMR | director | 272,767 0.4999% | $37.76 | $10.3M | -29.51% | ||
| 2022-01-19 | Repare Therapeutics Inc. RPTX | 10 percent owner | 997,961 2.3789% | $14.10 | $14.07M | -4.25% | ||
| 2021-11-30 | Olema Pharmaceuticals, Inc. OLMA | 739,675 1.9974% | $9.39 | $6.95M | -52.69% | |||
| 2021-10-08 | Sale | Merus N.V. MRUS | 10 percent owner | 147,267 0.3769% | $27.79 | $4.09M | -9.47% |